Results 41 to 50 of about 12,382 (211)
Reachable Workspace as a Clinical Outcome for Upper Extremity Function: A Narrative Review
Muscle &Nerve, EarlyView.ABSTRACT Motion sensing technology can be utilized to capture detailed upper extremity (UE) motion to reconstruct an individual's three‐dimensional (3D) reachable workspace (RWS). The RWS can be quantified as relative surface area (RSA), providing an innovative surrogate measure to assess UE mobility and function.
Jay J. Han +3 more
wiley +1 more source
Molecular PainObjective: This study aimed to investigate the specific manifestations and differences in brain network activity and functional connectivity between brain networks in patients with trigeminal neuralgia and migraine, aiming to reveal the neural basis of ...
Qichen Zhou +8 more
doaj +1 more source
Cancer pain: current practice and emerging targets
British Journal of Pharmacology, EarlyView.Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
针刺研究, 2021 Objective To investigate the application characteristics of electroacupuncture(EA) in the treatment of peripheral neuropathy, so as to provide a basis for clinical use of EA therapy. Methods Keywords of "electroacupuncture""peripheral neuropathy" "facial
ZHANG Zi-di +8 more
doaj
Peripheral targets for neuropathic pain
British Journal of Pharmacology, EarlyView.Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour +3 more
wiley +1 more source
Cannabinoids in trigeminal neuralgia
Pathos, 2021 Trigeminal neuralgia is the most common craniofacial pain syndrome. This disorder causes severe facial pain and is described as very acute, similar to an electric shock to the jaw, eye region, teeth or gums.
Antonino Genovese +2 more
doaj
Evolving treatments for Sjögren disease: current approaches and emerging targets
Internal Medicine Journal, EarlyView.Abstract Sjögren disease (SjD) is a prevalent systemic autoimmune condition characterised by exocrine gland dysfunction, systemic inflammation and heterogeneous organ involvement. Current management remains largely symptomatic, with no approved disease‐modifying therapies available and substantial unmet clinical need. However, advances in understanding
Mansi Bhurani +3 more
wiley +1 more source
Trigeminal Neuralgia Etiologi, Patofisiologi, dan Tatalaksana
, 2019 Neuralgia trigeminal is unilateral, chronic and recurring facial pain syndromes, in which pain is distributed following trigeminal nerve branches and is commonly found in healthcare practice.
Gunawan, Pricilla Y, Dina, Annisa
core +1 more source
Peripheral neurectomy in treatment of trigeminal neuralgia: A case report
Journal of Indian Academy of Oral Medicine and Radiology, 2017 Neuropathic pain is nonadaptive and does not contribute to healing, such as would be the case with pain attributable to tissue inflammation, where pain results in adaptive behaviors, such as use limitation, guarding, rest, and avoidance, which contribute
Abhijeet Alok +3 more
doaj +1 more source
Journal of Oral Rehabilitation, EarlyView.A compounded amitriptyline 10% plus lidocaine 2% mucoadhesive gel was associated with substantial pain improvement and favourable tolerability in adults with post‐traumatic trigeminal neuropathic pain (PTNP). These findings support targeted mucosal delivery as a promising practical local option and a potential medication‐sparing strategy, particularly ...
Ashley Lebel +2 more
wiley +1 more source